Vestal Point Capital’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$236M Buy
435,000
+360,000
+480% +$203M 5.51% 4
2026
Q1
$44.5M Buy
+75,000
New +$37.4M 1.24% 31

Other funds holding UTHR

Vestal Point Capital's UTHR Position: Q2 2026 in Review

Vestal Point Capital increased its United Therapeutics (UTHR) stake by 480% in Q2 2026, buying an estimated $203M and bringing the position to 435,000 shares worth $236M. The position accounts for 5.51% of the portfolio, ranked #4.

Vestal Point Capital first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Vestal Point Capital held 435,000 shares of United Therapeutics worth $236M as of Q2 2026.
  • Vestal Point Capital bought 360,000 United Therapeutics shares in Q2 2026, an estimated $203M.
  • United Therapeutics made up 5.51% of Vestal Point Capital's portfolio in Q2 2026, its #4 holding.
  • Vestal Point Capital first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.